How much funding has Parambil raised?

Parambil has raised $8.0M in total funding. Their latest funding round was Seed. Key investors include Bling Capital, Daybreak Ventures, nvp capital, Techstars.

Where is Parambil headquartered?

Parambil is headquartered in New York, USA. The company has a team of 10-50 people.

What does Parambil do?

Parambil operates in the AI in Legal sector. An agentic AI case-intelligence platform that automates medical record review, investigation, and drafting for complex litigation (mass torts, PI, med mal). Accelerates medical record review by 95% while improving data accuracy by 44% compared to traditional human-only methods, enabling legal teams to identify key facts faster and more reliably.

When was Parambil founded?

Parambil was founded in 2023. It is based in New York, USA.

How much funding has Parambil raised?

Parambil has raised $8.0M in total funding. Key investors include Bling Capital, Daybreak Ventures, nvp capital, Techstars.

Who is the CEO of Parambil?

Sara Dwyer is the CEO of Parambil. The company was founded in 2023.

Where is Parambil located?

Parambil is headquartered in New York, USA.

What funding stage is Parambil at?

Parambil is currently at the Seed stage.

How many employees does Parambil have?

Parambil has approximately 10-50 employees.

Parambil

Category: AI in Legal

An agentic AI case-intelligence platform that automates medical record review, investigation, and drafting for complex litigation (mass torts, PI, med mal). Parambil was founded in 2023. The company is led by Sara Dwyer. Based in New York, USA. Team size: 10-50. Total funding raised: $8.0M. Latest round: Seed. Key investors include Bling Capital, Daybreak Ventures, nvp capital, Techstars.

Founded: 2023
Headquarters: New York, USA
Team size: 10-50
Total funding: $8.0M

Value proposition

Accelerates medical record review by 95% while improving data accuracy by 44% compared to traditional human-only methods, enabling legal teams to identify key facts faster and more reliably.

Products and solutions

Agentic AI Platform for Complex Litigation, Case Counsel (investigation agent), Quill (drafting agent), Research / Web Search Agent (Perplexity), Vault (file organization agent), Medical Chronologies & Case Intake, Mass Tort / PI Litigation Dashboards

Unique value

Combines high-level management consulting expertise with advanced AI (QuantumBlack/McKinsey background) to solve the specific bottleneck of medical data extraction in the legal industry, having already processed over 5 million records.

Target customer

Plaintiff and defense law firms in mass torts, personal injury, medical malpractice, birth injury, and nursing home abuse; corporate defendants managing complex injury claims.

Industries served

Legal Technology (LegalTech), Healthcare, Life Sciences, Insurance Litigation

Technology advantage

Proprietary AI architecture capable of extracting and validating complex clinical data with 95% faster turnaround times and significantly higher accuracy than manual paralegal or medical expert reviews.

How they differentiate

Leverages proprietary AI architecture developed by former McKinsey QuantumBlack experts to extract and validate complex clinical data with 95% faster turnaround and 44% higher accuracy than manual paralegal reviews.

Main competitors

EvenUp, Wisedocs, Clearbrief

Key partnerships

Bling Capital (Seed lead), Daybreak Ventures (Pre-Seed lead), nvp capital, Perplexity (Web Search Agent / BAA partnership), QuantumBlack (Alumni network/methodological influence)

Notable customers

Kline & Specter, Edelson PC, Kershaw Talley Barlow, Hoes Milman, Cory Watson (logo), Hundreds of U.S. law firms (mass torts, PI, med mal), Corporate defendants including a major cruise line

Major milestones

Founded in 2023 by Sara Dwyer (CEO), Liam Gordon (CTO), and Dr. Ralph Horwitz (CMO); Techstars 2023, Secured $2M Pre-Seed led by Daybreak Ventures in January 2025, Raised $6M Seed led by Bling Capital (with nvp capital) in January 2026; ~$8M total, Launched agentic AI platform (Case Counsel, Quill, Research, Vault) in February 2026, Processed 5M+ medical records; 95% faster vs traditional methods; 44% accuracy lift

Growth metrics

Processed over 5 million medical records; achieved 95% faster turnaround times compared to traditional methods.

Market positioning

Litigation-grade agentic Legal AI for high-stakes medical complexity across mass torts, personal injury, and medical malpractice—serving both plaintiff and defense.

Geographic focus

United States (Headquartered in New York)

Patents and IP

No registered patents disclosed as of latest update

About Sara Dwyer

Sara Dwyer is the Founder and CEO of Parambil. Prior to founding the company in 2023, she was an Engagement Manager at McKinsey & Company (2019–2023), specifically within QuantumBlack, McKinsey's AI arm. Her expertise focuses on the intersection of life sciences, healthcare, and artificial intelligence. She holds a degree in Computer Science from the University of Pennsylvania.

More AI in Legal companies

Official website: https://www.parambil.com/